Measles-Mumps-Rubella Vaccine

DRUG5 trials

Sponsors

Sichuan Center for Disease Control and Prevention, Assiut University, Kasr El Aini Hospital, B.P. Koirala Institute of Health Sciences, Liaoning Chengda Biotechnology CO., LTD

Conditions

Common WartCovid19Japanese EncephalitisMeaslesMumpsPlantar WartRotavirusRubella

Phase 3

Measles Vaccine in HCW

SuspendedNCT04357028

Kasr El Aini HospitalCovid19

Start: 2020-07-13End: 2021-01-01Target: 200Updated: 2020-12-22

Phase 4

The Safety and Immunogenicity Study of Rotavirus Vaccine Simultaneously Vaccinated With MR or MMR Vaccine

Sichuan Center for Disease Control and PreventionRotavirus

Start: 2013-12-31End: 2014-08-31Target: 2800Updated: 2014-06-03

Intralesional Measles, Mumps, Rubella (MMR) Vaccine Versus Cryotherapy in Treatment of Multiple Common and Planter Warts

CompletedNCT03183765

Assiut UniversityCommon Wart, Plantar Wart

Start: 2017-08-01End: 2018-05-01Updated: 2020-06-16

Immunogenicity of Japanese Encephalitis Vaccine Co-administered With Measles-Mumps-Rubella Vaccine (MMR)

CompletedNCT06331702

Liaoning Chengda Biotechnology CO., LTDJapanese Encephalitis, Measles, Mumps +1

Start: 2024-03-02End: 2025-02-11Updated: 2025-08-28

Unknown Phase

A Comparative Study to Assess Efficacy of Intralesional MMR Vaccine and Intralesional Vitamin D3 in Treatment of Warts

CompletedNCT04428359

B.P. Koirala Institute of Health SciencesVerruca Viral

Start: 2020-06-01End: 2021-01-30Updated: 2021-04-09

Related Papers

A Comparative Prospective Study to Assess Efficacy of Intralesional MMR (Measles, Mumps, Rubella) Vaccine and Intralesional Vitamin D3 in Treatment of Nongenital Warts

Health Science Reports2025-05-011 citations